These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

747 related items for PubMed ID: 9263138

  • 1. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
    Wolfe F.
    J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
    [Abstract] [Full Text] [Related]

  • 2. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
    Ranganath VK, Elashoff DA, Khanna D, Park G, Peter JB, Paulus HE, Western consortium of practicing rhuemotologists.
    J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Paulus HE, Ramos B, Wong WK, Ahmed A, Bulpitt K, Park G, Sterz M, Clements P.
    J Rheumatol; 1999 Nov; 26(11):2324-31. PubMed ID: 10555885
    [Abstract] [Full Text] [Related]

  • 5. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
    Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, van der Tempel H, van der Linden S.
    J Rheumatol; 1999 Apr; 26(4):980-4. PubMed ID: 10229432
    [Abstract] [Full Text] [Related]

  • 6. Serum amyloid A in the assessment of early inflammatory arthritis.
    Cunnane G, Grehan S, Geoghegan S, McCormack C, Shields D, Whitehead AS, Bresnihan B, Fitzgerald O.
    J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
    [Abstract] [Full Text] [Related]

  • 7. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity.
    Emlen W, Niebur J, Flanders G, Rutledge J.
    J Rheumatol; 1996 Jun; 23(6):974-8. PubMed ID: 8782125
    [Abstract] [Full Text] [Related]

  • 8. High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis.
    Dessein PH, Joffe BI, Stanwix AE.
    J Rheumatol; 2004 Jun; 31(6):1095-7. PubMed ID: 15170920
    [Abstract] [Full Text] [Related]

  • 9. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K.
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [Abstract] [Full Text] [Related]

  • 10. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?
    Soubrier M, Zerkak D, Gossec L, Ayral X, Roux C, Dougados M.
    J Rheumatol; 2006 Jul; 33(7):1243-6. PubMed ID: 16622906
    [Abstract] [Full Text] [Related]

  • 11. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
    Cantini F, Salvarani C, Olivieri I, Macchioni L, Ranzi A, Niccoli L, Padula A, Boiardi L.
    Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
    [Abstract] [Full Text] [Related]

  • 12. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate.
    Mallya RK, de Beer FC, Berry H, Hamilton ED, Mace BE, Pepys MB.
    J Rheumatol; 1982 Aug; 9(2):224-8. PubMed ID: 7097681
    [Abstract] [Full Text] [Related]

  • 13. [Observation on effect of double filtration plasmapheresis on patients with active rheumatoid arthritis in active stage].
    Yu XX, Xu P, Gao P, Ma JR, Tian JG, Jiang SH, Ping LF, Gao N, Han HP, Wang LX.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):568-9. PubMed ID: 16146609
    [Abstract] [Full Text] [Related]

  • 14. Relative sensitivity to change of the erythrocyte sedimentation rate and serum C-reactive protein concentration in rheumatoid arthritis.
    Ward MM.
    J Rheumatol; 2004 May; 31(5):884-95. PubMed ID: 15124246
    [Abstract] [Full Text] [Related]

  • 15. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis.
    Yildirim K, Karatay S, Melikoglu MA, Gureser G, Ugur M, Senel K.
    Ann Clin Lab Sci; 2004 May; 34(4):423-6. PubMed ID: 15648784
    [Abstract] [Full Text] [Related]

  • 16. Thrombin-cleaved osteopontin is increased in urine of patients with rheumatoid arthritis.
    Shio K, Kobayashi H, Asano T, Saito R, Iwadate H, Watanabe H, Sakuma H, Segawa T, Maeda M, Ohira H.
    J Rheumatol; 2010 Apr; 37(4):704-10. PubMed ID: 20156944
    [Abstract] [Full Text] [Related]

  • 17. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK, El-Ansary AK, El-Eishi HH, Kamal HM, El-Saeed NH.
    Ital J Biochem; 2005 Apr; 54(3-4):248-57. PubMed ID: 16688934
    [Abstract] [Full Text] [Related]

  • 18. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
    De Rycke L, Verhelst X, Kruithof E, Van den Bosch F, Hoffman IE, Veys EM, De Keyser F.
    Ann Rheum Dis; 2005 Feb; 64(2):299-302. PubMed ID: 15166003
    [Abstract] [Full Text] [Related]

  • 19. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S, Cvetkovic JT, Sundqvist KG, Lefvert AK, Rantapää-Dahlqvist S.
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [Abstract] [Full Text] [Related]

  • 20. Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis.
    Ellingsen T, Buus A, Stengaard-Pedersen K.
    J Rheumatol; 2001 Jan; 28(1):41-6. PubMed ID: 11196541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.